StockData
Erasca, Inc. logo

Erasca, Inc. (ERAS) stock

ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$14.22+0.46 (+3.34%)

Close on Nov 19, 2026Market cap $4.97BP/E –Yield 0.00%

Erasca shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Erasca's shares outstanding was 311M at Jun 30, 2026. For fiscal 2025 it was 284M, up 21.3% from the year before. The highest annual figure on record is 284M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025284M+21.3%
FY2024Dec 31, 2024234M+55.7%
FY2023Dec 31, 2023150M+23.1%
FY2022Dec 31, 2022122M+84.1%
FY2021Dec 31, 202166M+215.1%
FY2020Dec 31, 202021M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026311M+9.9%
Q1 FY2026Mar 31, 2026304M+7.4%
Q4 FY2025Dec 31, 2025284M+0.2%
Q3 FY2025Sep 30, 2025284M+0.5%
Q2 FY2025Jun 30, 2025283M+30.1%
Q1 FY2025Mar 31, 2025283M+87.4%
Q4 FY2024Dec 31, 2024283M+87.9%
Q3 FY2024Sep 30, 2024282M+87.7%
Q2 FY2024Jun 30, 2024218M+45.2%
Q1 FY2024Mar 31, 2024151M+1.1%
Q4 FY2023Dec 31, 2023151M+18.1%
Q3 FY2023Sep 30, 2023150M+24.5%
Q2 FY2023Jun 30, 2023150M+24.8%
Q1 FY2023Mar 31, 2023150M+25.1%
Q4 FY2022Dec 31, 2022128M+6.9%
Q3 FY2022Sep 30, 2022121M+21.9%
Q2 FY2022Jun 30, 2022120M+410.5%
Q1 FY2022Mar 31, 2022119M+437.4%
Q4 FY2021Dec 31, 2021119M+452.9%
Q3 FY2021Sep 30, 202199M+370.1%
Q2 FY2021Jun 30, 202124M+13.0%
Q1 FY2021Mar 31, 202122M–
Q4 FY2020Dec 31, 202022M–
Q3 FY2020Sep 30, 202021M–
Q2 FY2020Jun 30, 202021M–

More Erasca figures

See a number that looks wrong?